News

December 16, 2019December 16, 2019

EU Grants Patent to TNX-102 SL, Oral Muscle Relaxant for Fibromyalgia in New Phase 3 Trial

News

The European Patent Office (EPO) has issued a patent covering the intellectual rights to the composition and formulation of TNX-102 SL, Tonix Pharmaceuticals’ investigational under-the-tongue muscle relaxant now in pivotal ... Read more

December 11, 2019December 11, 2019

Men Support Female Partners With Fibromyalgia Despite Impact on Sexuality, Study Finds

News

While fibromyalgia profoundly compromises a couple’s sex life, a study has found that male partners of women diagnosed with the condition essentially respond by fostering support and fighting for the ... Read more

December 9, 2019December 18, 2019

Fibromyalgia in Younger People More Likely Driven by Genetics, Large Study Suggests

News

Genetics seem to be playing a larger role in driving the development of fibromyalgia in patients, 50 or younger, than in those who are older and more likely to have ... Read more

December 6, 2019December 6, 2019

Tetra Bio-Pharma, Alternavida Join Forces to Develop Cannabinol Product Caumz for Chronic Pain

News

Tetra Bio-Pharma and Alternavida have established a collaboration agreement to allow the clinical development, marketing, and distribution of the cannabis-derived medicine Caumz (PPP011) in Mexico. This agreement will potentially accelerate ... Read more

December 4, 2019December 4, 2019

TENS Treatment Eases Pain and Fatigue of Fibromyalgia, Phase 2 Trial Shows

News

Four weeks of transcutaneous electrical nerve stimulation (TENS) ease the pain and fatigue associated with movement in women with fibromyalgia (FM), a Phase 2 study showed. Findings from the study, ... Read more

November 25, 2019November 25, 2019

New Phase 3 Trial of Non-opioid Pain Relief Tablet to Open in US, Tonix Says

News

Tonix Pharmaceuticals announced it is opening a new Phase 3 trial to evaluate the efficacy and safety of its investigational therapy TNX-102 SL, a sublingual tablet, in easing the widespread pain ... Read more

November 18, 2019November 18, 2019

Pain Levels, Disability Greater in Children with Fibromyalgia Than with Other Rheumatic Diseases, Study Finds

News

Young people with juvenile fibromyalgia report higher pain levels and show greater “functional disability” affecting daily life than do children with other rheumatic diseases, a recent study reports. However, these ... Read more

November 15, 2019November 15, 2019

New Phase 2 Trial to Test NYX-2925 as Potential Fibromyalgia Therapy

News

A new Phase 2 clinical trial will continue to assess the safety and effectiveness of the non-opioid small molecule candidate therapy NYX-2925, developed by Aptinyx, in fibromyalgia patients. NYX-2925 is an oral ... Read more

November 13, 2019November 13, 2019

TNX-102 SL Holds Potential to Treat FM Symptoms, Phase 3 Trial Data Show

News

The investigational therapy TNX-102 SL (sublingual cyclobenzaprine) had significant beneficial impact on sleep quality and fatigue, although it did not reduce pain levels in patients with fibromyalgia, results from a ... Read more

November 11, 2019November 11, 2019

Women With Fibromyalgia Take Sick Leave for Workplace Reasons, Not Disease Issues, French Study Suggests

News

Women with fibromyalgia frequently take sick leave, but for workplace-specific reasons rather than due to disease-related issues, a French study suggests. The study, titled “Fibromyalgia in the workplace: risk factors ... Read more